fluorodeoxyglucose f18 has been researched along with Nervous System Disorders in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.71) | 18.7374 |
| 1990's | 1 (2.86) | 18.2507 |
| 2000's | 8 (22.86) | 29.6817 |
| 2010's | 19 (54.29) | 24.3611 |
| 2020's | 5 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Tian, M; Wang, A; Wu, S; Zhang, H; Zhang, T; Zhang, X | 1 |
| Borsook, D; Fox, MD; Joutsa, J; Kim, NY; Kim, YW; Li, J; Peyron, R; Quesada, C; Taylor, JJ | 1 |
| Arulogun, S; Bomanji, J; Priftakis, D; Riaz, S; Wan, S | 1 |
| Albano, D; Bertagna, F; Dondi, F; Giubbini, R; Paghera, B | 1 |
| Benedet, AL; Chan, YH; Gauthier, S; Greenwood, CMT; Jiang, L; Kandiah, N; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Therriault, J | 1 |
| Arbizu, J; Gállego Perez-Larraya, J; García-García, B; Giuliani, A; Imaz, L; Jonsson, C; Morales, M; Pagani, M; Riverol, M | 1 |
| Blake, J; Pissanou, T; Reilly, MM; Rossor, AM | 1 |
| Bund, C; De Seze, J; Kremer, S; Lhermitte, B; Namer, IJ | 1 |
| Gómez-Vallejo, V; Joya, A; Llop, J; Martín, A; Padro, D; Plaza-García, S | 1 |
| Dong, Z; Girling, K; Lee, W; Lin, SZ; Shyu, WC; Taghibiglou, C; Wang, YT; Zhang, S | 1 |
| de Cristóbal, J; Delgado, M; Garcia-Garcia, L; Medina, M; Pozo, MA | 1 |
| Beltran, LS; Chandarana, H; Friedman, KP; Geppert, C; Ponzo, F; Rakheja, R; Seltzer, AL | 1 |
| Cui, D; Liang, S; Shang, H; Yang, D; Zhang, W; Zhao, W | 1 |
| Zhang, J | 1 |
| Bormann, T; Buchert, R; Frings, L; Heimbach, B; Hellwig, S; Klöppel, S; Meyer, PT; Minkova, L; Spehl, TS; Vach, W | 1 |
| Doruyter, A; Sathekge, M; Vorster, M; Warwick, JM | 1 |
| Amo-Salas, M; de Ayala Fernández, JÁ; Del Saz Saucedo, P; García Vicente, AM; Garrido Robles, JA; López-Fidalgo, JF; Muñoz Pasadas, M; Pena Pardo, FJ; Soriano Castrejón, A | 1 |
| Dhawan, V; Eidelberg, D | 1 |
| Gobbelé, R; Ludolph, A; Meyer, PT; Schaefer, WM; Schiel, M; Waberski, TD | 1 |
| Adam, G; Bannas, P; Derlin, T; Klutmann, S; Lambert, J; Leypoldt, F; Mester, J; Weber, C | 1 |
| Hwangbo, B; Im, HJ; Kim, HJ; Kim, SK; Kim, TS; Kim, W | 1 |
| Coenen, HH; Elsinga, PH; Iwata, R; Kilbourn, MR; Pillai, MR; Rajan, MG; Wagner, HN; Zaknun, JJ | 1 |
| Hirata, Y; Hosoya, Y; Inajima, T; Ishizaka, N; Nagai, R; Shimizu, T; Takahashi, M; Takeda, N; Yamashita, H | 1 |
| Cheng, YK; Hsiao, IT; Lin, KJ; Wang, TC; Wey, SP; Yen, TC | 1 |
| Eicker, S; Floeth, FW; Galldiks, N; Herdmann, J; Langen, KJ; Rhee, S; Steiger, HJ; Stoffels, G | 1 |
| Drubach, DA; Graff-Radford, J; Josephs, KA; Strand, EA | 1 |
| Bakshi, R; Dubey, N; Mechtler, LL; Miletich, RS; Wasay, M | 1 |
| Alavi, A; Kung, JW; Lakhani, P; Mavi, A; Zhuang, H | 1 |
| Brand, M; Kalbe, E; Kessler, J; Kracht, LW; Markowitsch, HJ; Münch, J; Riebel, U | 1 |
| Momose, T | 1 |
| Dodick, D; Roarke, M | 1 |
| Al-Essa, M; Al-Shamsan, L; Bakheet, S; Ozand, PT; Patay, Z; Powe, J | 1 |
| Andresen, B; Buchert, R; Obrocki, J; Petersen, K; Schmoldt, A; Thomasius, R | 1 |
| Firnau, G; Garnett, ES; Levin, SD; Nahmias, C; Nobbs, PT; Sinclair, JC; Thorp, PS; Toi, A; Upton, AR | 1 |
| Heiss, WD; Herholz, K; Pawlik, G; Wagner, R; Wienhard, K | 1 |
8 review(s) available for fluorodeoxyglucose f18 and Nervous System Disorders
| Article | Year |
|---|---|
Spatial normalization and quantification approaches of PET imaging for neurological disorders.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Nervous System Diseases; Positron-Emission Tomography | 2022 |
Emerging clinical issues and multivariate analyses in PET investigations.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Multivariate Analysis; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
Topics: Equipment Design; Fluorodeoxyglucose F18; Forecasting; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Nervous System Diseases; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Risk Factors | 2014 |
How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer's disease and other neurological disorders.
Topics: Alzheimer Disease; Animals; Arteries; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nervous System Diseases; Oxygen Isotopes; Positron-Emission Tomography; Rats; Spin Labels; Tomography, Emission-Computed, Single-Photon | 2016 |
Positron emission tomography imaging in human immunodeficiency virus-1-associated neurocognitive disorders: an interesting case and a review of the positron emission tomography literature.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; HIV Infections; HIV-1; Humans; Magnetic Resonance Imaging; Middle Aged; Nervous System Diseases; Positron-Emission Tomography | 2009 |
Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Neoplasms; Nervous System Diseases; Radionuclide Imaging; Radiopharmaceuticals | 2010 |
PET: a revolution in medical imaging.
Topics: Fluorodeoxyglucose F18; Humans; Molecular Biology; Neoplasms; Nervous System Diseases; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
[Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders].
Topics: Adult; Brain; Brain Neoplasms; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Nervous System Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Synaptic Transmission | 2007 |
1 trial(s) available for fluorodeoxyglucose f18 and Nervous System Disorders
| Article | Year |
|---|---|
Specific neurotoxicity of chronic use of ecstasy.
Topics: Adolescent; Adult; Brain; Female; Fluorodeoxyglucose F18; Glucose; Hallucinogens; Humans; Linear Models; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Tomography, Emission-Computed | 2002 |
26 other study(ies) available for fluorodeoxyglucose f18 and Nervous System Disorders
| Article | Year |
|---|---|
Network Effects of Brain Lesions Causing Central Poststroke Pain.
Topics: Brain; Connectome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nervous System Diseases; Neuralgia; Pain Measurement; Transcranial Magnetic Stimulation | 2022 |
Before and After Treatment Characterization of Cerebrospinal Disease in Bing-Neel Syndrome Using 18F FDG PET/MRI.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nervous System Diseases; Positron-Emission Tomography; Waldenstrom Macroglobulinemia | 2020 |
18F-FDG PET/CT in the Diagnosis and Follow-up of Balint Syndrome.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nervous System Diseases; Positron Emission Tomography Computed Tomography | 2021 |
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
Topics: Adult; Age of Onset; Aged; Alzheimer Disease; Disease Progression; Factor Analysis, Statistical; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Mutation; Nervous System Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Sensory neuronopathy associated with cholangiocarcinoma diagnosed 6 years after symptom onset.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nervous System Diseases; Neural Conduction; Outcome Assessment, Health Care; Positron-Emission Tomography; Sensation Disorders; Time Factors; Wheelchairs | 2017 |
FDG PET and MRI Findings in a Case of Bing-Neel Syndrome.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron Emission Tomography Computed Tomography; Vidarabine | 2018 |
PET Imaging of Crossed Cerebellar Diaschisis after Long-Term Cerebral Ischemia in Rats.
Topics: Animals; Brain Ischemia; Cerebellum; Fluorodeoxyglucose F18; Glucose; Humans; Nervous System Diseases; Positron-Emission Tomography; Rats; Recovery of Function; Regional Blood Flow; Stroke; Time Factors | 2018 |
Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries.
Topics: Animals; Brain; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Agonists; Female; Fluorodeoxyglucose F18; Green Fluorescent Proteins; L-Lactate Dehydrogenase; Male; Mice; Mutation; N-Methylaspartate; Nervous System Diseases; Neurons; Nuclear Localization Signals; Peptides; Pregnancy; Protein Transport; PTEN Phosphohydrolase; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 2013 |
A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3β in the brain.
Topics: Animals; Brain; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Longitudinal Studies; Mice; Mice, Transgenic; Nervous System Diseases; Positron-Emission Tomography | 2014 |
The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage.
Topics: Animals; Antipyrine; Behavior, Animal; Body Water; Brain Edema; Cell Death; Edaravone; Fluorodeoxyglucose F18; Free Radical Scavengers; Glucose; Intracranial Hemorrhages; Male; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Stroke | 2015 |
Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Retrospective Studies; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon | 2015 |
Appropriate indications for positron emission tomography/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Infections; Inflammation; Neoplasms; Nervous System Diseases; Positron-Emission Tomography; South Africa; Tomography, X-Ray Computed | 2015 |
Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Nervous System Diseases; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2017 |
Positron emission tomography imaging.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Nerve Net; Nervous System Diseases; Positron-Emission Tomography | 2009 |
18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2010 |
F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nervous System Diseases; Positron-Emission Tomography; Radiography, Thoracic; Sarcoidosis; Thymidine; Tomography, X-Ray Computed | 2010 |
A case of localized IgG4-related thoracic periarteritis and recurrent nerve palsy.
Topics: Adult; Aorta, Thoracic; Arteritis; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2011 |
Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging.
Topics: Animals; Autoradiography; Brain Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Locomotion; Male; Nervous System Diseases; Neurologic Examination; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Survival Analysis; Touch; Visual Perception | 2011 |
Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.
Topics: Aged; Aged, 80 and over; Cervical Vertebrae; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Orthopedic Procedures; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Software; Spinal Cord Compression; Spinal Cord Diseases; Spinal Stenosis; Treatment Outcome | 2011 |
Fluorodeoxyglucose F18 PET in progressive emotional dysprosody.
Topics: Emotions; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Humans; Middle Aged; Multilingualism; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Speech Disorders | 2012 |
Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nervous System Diseases; Radiopharmaceuticals; Sarcoidosis; Spine; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Organic and psychogenic factors leading to executive dysfunctions in a patient suffering from surgery of a colloid cyst of the Foramen of Monro.
Topics: Adult; Brain Diseases; Cerebral Ventricles; Cognition; Cysts; Emotions; Female; Fluorodeoxyglucose F18; Humans; Nervous System Diseases; Neuropsychological Tests; Neurosurgical Procedures; Positron-Emission Tomography; Postoperative Complications; Psychomotor Performance; Radiopharmaceuticals; Social Behavior | 2004 |
Familial hemiplegic migraine: permanent attack-related neurologic deficits.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Migraine with Aura; Nervous System Diseases; Positron-Emission Tomography; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2007 |
18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Topics: Brain; Brain Diseases; Child; Child, Preschool; Fluorodeoxyglucose F18; Glutarates; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Nervous System Diseases; Optic Atrophy; Paraplegia; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant.
Topics: Brain; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant, Newborn; Male; Nervous System Diseases; Organ Specificity; Tomography, Emission-Computed | 1988 |
Positron emission tomography in neuropsychology.
Topics: Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Mathematics; Models, Biological; Nervous System Diseases; Neuropsychology; Perception; Reference Values; Tomography, Emission-Computed | 1986 |